ALT #InnovationSanDiego is where #medtech innovation meets opportunity. Join investors, start-ups, and strategics Nov 3-5, 2026: https://bit.ly/3PtRwUB
Your next #medtech read is on us. Get industry insights from experienced analysts with a complimentary print issue of MedTech Strategist: bit.ly/4xJTtMN
ALT Your next #medtech read is on us. Get industry insights from experienced analysts with a complimentary print issue of MedTech Strategist: https://bit.ly/4xJTtMN
From funding to FDA, it’s all on the agenda. The #InnovationSanDiego 2026 agenda is officially live! Explore the sessions, speakers and conversations ahead: bit.ly/4hDJkfD
ALT From funding to FDA, it’s all on the agenda. The #InnovationSanDiego 2026 agenda is officially live! Explore the sessions, speakers and conversations ahead: https://bit.ly/4hDJkfD
9+ areas of coverage. One place to stay connected to #medtech. From executive interviews and start-ups to M&A, emerging markets and industry strategy, MedTech Strategist goes beyond the headlines: bit.ly/4ycwnzs
ALT 9+ areas of coverage. One place to stay connected to #medtech. From executive interviews and start-ups to M&A, emerging markets and industry strategy, MedTech Strategist goes beyond the headlines: https://bit.ly/4ycwnzs
The next 10 years could transform spine surgery. Rajiv Sethi, MD, PhD, shares how #AI, value-based care and better #tech evaluation could shape its future. Read more: bit.ly/46xSHaD
ALT The next 10 years could transform spine surgery. Rajiv Sethi, MD, PhD, shares how #AI, value-based care and better #tech evaluation could shape its future. Read more: https://bit.ly/46xSHaD
The latest MedTech Strategist digital edition is here. Explore what’s happening across urology, cardiogenic shock, heart transplant technology, #medtech investment and more: bit.ly/4hCStVR
ALT The latest MedTech Strategist digital edition is here. Explore what’s happening across urology, cardiogenic shock, heart transplant technology, #medtech investment and more: https://bit.ly/4hCStVR
67% AF. 47% bradyarrhythmias/pauses. 20% VT/VF. ALLEVIATE-HF uncovered a striking arrhythmia burden across the heart failure spectrum, with implications for future drugs and #medicaldevices: bit.ly/4itQHr9
ALT 67% AF. 47% bradyarrhythmias/pauses. 20% VT/VF.
ALLEVIATE-HF uncovered a striking arrhythmia burden across the heart failure spectrum, with implications for future drugs and #medicaldevices: https://bit.ly/4itQHr9
• @StephenLevinMTS, Co-Editor-in-Chief/ Managing Partner
• Sandy Corbett, Director of Operations
• @Filmoreorless, Executive Editor, Market Pathways
• Andrea Mancini, Senior Director of Commercial Operations
• Brenda Belt, Research Analyst
Join 4,000 leaders from 1,800+ companies and 38+ countries at @MedTechCon 2026, hosted by @AdvaMedEvents, October 18–21.
Register for #MTC26 to secure the best available rate, preferred housing, and be part of the conversations moving #medtech forward: bit.ly/4yJpiWW
10,367 TAVI procedures were performed in the UK from 2024–2025. NICE’s new draft guidance on cerebral protection #medicaldevices during TAVI is now in Document Depot. Read the rest of the doc here: bit.ly/4heswdO
CDRH Director Michelle Tarver, MD, PhD, joins
@Filmoreorless of @Market_Pathways at #InnovationSummit this year for an opening keynote & fireside chat on TAP, early feasibility studies, FDA-CMS alignment, #AI, cybersecurity & more. Bring your questions: bit.ly/4h7JsTs
ALT CDRH Director Michelle Tarver, MD, PhD, joins
@Filmoreorless of @Market_Pathways at #InnovationSummit this year for an opening keynote & fireside chat on TAP, early feasibility studies, FDA-CMS alignment, #AI, cybersecurity & more. Bring your questions: https://bit.ly/4h7JsTs
1
1
3
129
MedTech Strategist | MedTech's Most Trusted Source retweeted
160 #policy documents from 24 agencies in just two months. From AI and BCIs to Breakthrough Devices, #medtech policy had a busy summer. Here are 5 developments worth watching: bit.ly/3VaYHn6
ALT 160 #policy documents from 24 agencies in just two months. From AI and BCIs to Breakthrough Devices, #medtech policy had a busy summer. Here are 5 developments worth watching: https://bit.ly/3VaYHn6
4 new clearances, major M&A deals, and Big Tech moving deeper into #healthcare. 📈
From AI-powered imaging to diagnostics, remote monitoring and wearables, here’s a snapshot of what’s moving #MedTech forward. 👇
ALT 4 new clearances, major M&A deals, and Big Tech moving deeper into #healthcare. 📈
From AI-powered imaging to diagnostics, remote monitoring and wearables, here’s a snapshot of what’s moving #MedTech forward. 👇
In 2014, along with partner Stephen Levin, he launched Innovation in Medtech, publishers of MedTech Strategist and Market Pathways and organizers of the Medtech Innovation Summit series of investor conferences in Dublin and San Diego.
Over the course of the past 35+ years, David was widely known throughout the device industry through his articles, conference interviews of CEOs and industry leaders, and appearances at company events.
More important than his vast industry knowledge and willingness to share his expertise, David will be remembered for his kindness of spirit, generosity of time and unfailing good humor, which touched everyone he met.
David was a true mensch and will be sorely missed.
In 1989, David, along with his partner Roger Longman, co-founded Windhover Information and for many years was the head of the #medtech team for both IN VIVO and Start-Up magazines.
In 2008, Windhover was acquired by Reed Elsevier where David was head of editorial for Elsevier Business Intelligence and oversaw the medical device coverage in IN VIVO, Start-Up, MedTech Insight, and the Gray Sheet.
He started working with his father, Albert Cassak, and his sister, Laurie Cassak, on Surgical Business, a leading publication in the hospital supply industry, as well as Health Industry Today, which covered home healthcare.